c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma. - Wikidata - wikimedia - TriplyDB

c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.

c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.

http://www.wikidata.org/entity/Q44255226

about

Relationship of PCNA, C-erbB2 and CD44s expression with tumor grade and stage in urothelial carcinomas of the bladder.HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review.Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection.Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker.Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer The Effects of Helicobacter pylori on the prognosis of patients with curatively resected gastric cancers in a population with high infection rate.Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma.Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Canc HER2 testing in gastric and esophageal adenocarcinoma: new diagnostic challenges arising from new therapeutic options.An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis.Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial.Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas.Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature.A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages.Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers.

P2860

Q33911085-2F7D18DF-E0FE-416A-A419-3DF51F7F3EB0 Q34223664-BA975D7B-4635-440F-BABF-AC3EC5779CD9 Q34324291-A0CF00B5-3221-4004-A43E-3978AADDED0B Q34551144-6FA336B8-4B5D-44C3-9D11-E72AE134D96B Q34631121-8B234B80-858E-4484-B6F4-8D3732AF753B Q35565614-BA8CC314-4BD8-4242-A13A-2142D9941441 Q35594687-9D2A8BF3-1407-4EB5-B2CE-64BC086F3C71 Q35809359-023AF5D2-C808-41CE-AA3D-107DF89CD80D Q36220464-26072DFF-7993-43F0-AFC9-1E6F5FB4A2DE Q36306523-DBE6D842-3B6C-48E8-8BF9-3D6B6105117A Q37241496-2A16FB94-37B1-452D-90E8-208EC253444F Q37590066-CDED760D-2F18-4FC7-B04E-7E9A13BB1F28 Q37717190-5BB342A3-E1FB-451D-AE74-BCBA08F137F6 Q37899910-D97589A2-C4E3-4A28-9860-94070554D698 Q38691748-B7B88549-EC5D-4046-9787-84D7E2C17F59 Q43712233-2C459190-9890-4FFD-B29F-50DCBBBBB3BF Q44867167-7E68D1DA-4355-4593-965E-F5717CBD4390 Q53134672-CE2165B5-7039-4A26-8703-8889BE8C3C88 Q53347431-3B640C85-2065-46BF-B1E7-07D611ED7AFA Q53424338-9337E05F-728C-459D-B202-CEC17E437D84

P2860

c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.

http://www.wikidata.org/entity/Q44255226

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

c-erb B-2 expression is associ ...... tients with gastric carcinoma.

@en

c-erb B-2 expression is associ ...... tients with gastric carcinoma.

@nl

type

label

c-erb B-2 expression is associ ...... tients with gastric carcinoma.

@en

c-erb B-2 expression is associ ...... tients with gastric carcinoma.

@nl

prefLabel

c-erb B-2 expression is associ ...... tients with gastric carcinoma.

@en

c-erb B-2 expression is associ ...... tients with gastric carcinoma.

@nl

P1433

Q44255226-BB7FA0CE-9BB5-49ED-8BB1-4C1BE0FBDDED

P1476

Q44255226-608B4EEF-38B3-4FA8-90D9-B171E842919E

P2093

Q44255226-327198AF-8110-48FA-AA0D-88084CC06423

Q44255226-3D3A4984-8AD6-423E-8179-0F80F00B90A7

Q44255226-A7CBC05B-4A98-4AF8-95D2-48DF506D0E8C

Q44255226-C3E40844-3856-4EF1-8988-F6AF1F2ECA23

Q44255226-D4E29A36-C5A2-49CC-877A-EE17BDAC74B5

Q44255226-E7267632-467B-4A89-A673-F08799B1D422

P2860

Q44255226-0887732C-912E-4211-B5AF-713BA8758A7E

Q44255226-0DD2485D-0988-4576-BACB-1D1E3C93FA43

Q44255226-11969F5B-E6BF-4589-9EF2-ADBC55B4FC11

Q44255226-21BE7238-11E6-42C0-B542-B3052BE41053

Q44255226-2202DFB1-2EAF-4EEF-A7E0-B4AA35046A7C

Q44255226-2516F9FB-8462-4268-97DF-9291F7A60A4D

Q44255226-2F3B54F1-962E-492F-8086-810BA2B1289B

Q44255226-50FA18FD-0033-46B1-AA6D-9AB5D09D68AD

Q44255226-5472AFF8-44CE-4BD5-8760-F41692C1C291

Q44255226-89057BA9-CF13-4865-8480-C38BDFB39EA9

P304

Q44255226-F7826CA8-A25D-455E-A9B3-BD35CCA4D31B

P31

Q44255226-720A6E2D-D1B5-4C0A-830B-91F9218A76A8

P356

Q44255226-6BE64522-6E4B-4FE9-BC0E-50C7A55D5F65

P433

Q44255226-0125BB24-282F-4598-8A00-73842A3144E6

P478

Q44255226-7AF98328-3C5B-45D4-AAE5-1F5D1B0C069B

P50

Q44255226-43C5C1DC-CF52-4928-B8B4-BDB9F48F0E0E

P577

Q44255226-93908030-5D77-40FA-8451-49FA604F34A0

P698

Q44255226-CD80D27E-E2D8-4808-9F2A-E32B49786549

P356

106689690201000402

P1433

International Journal of Surgical Pathology

P1476

c-erb B-2 expression is associ ...... atients with gastric carcinoma

@en

P2093

Amadeu Pimenta

http://www.w3.org/2001/XMLSchema#string

Dina Leitão

http://www.w3.org/2001/XMLSchema#string

John R Preto

http://www.w3.org/2001/XMLSchema#string

João Pinto-de-Sousa

http://www.w3.org/2001/XMLSchema#string

Mário Seixas

http://www.w3.org/2001/XMLSchema#string

Raquel Almeida

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of heregulin, a specific activator of p185erbB2

Nonparametric Estimation from Incomplete Observations

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Biochemical markers in breast cancer: which ones are clinically useful?

Ongoing trials with trastuzumab in metastatic breast cancer.

Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe.

Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction.

Clinicopathologic profiles and prognosis of gastric carcinomas from the cardia, fundus/body and antrum.

P304

247-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/106689690201000402

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12490974

http://www.w3.org/2001/XMLSchema#string